Gillette (1975–1998)

1. Episode summary

When Colman M. Mockler Jr. was named chief executive of The Gillette Company in 1975, the company's wet-shaving franchise was under pressure from Bic's disposable razors, which had grown out of a niche in Europe and were cannibalising Gillette's cartridge revenue by trading closeness-of-shave for low-cost convenience. Mockler reversed the diversification drift of his predecessor, divesting marginal acquisitions (Buxton, Welcome Wagon, Hyponex, Autopoint) and concentrating capital on high-volume, repeat-purchase consumer categories where Gillette's manufacturing, distribution and blade-technology base could compound. Through the late 1970s and 1980s Gillette matched Bic in disposables (Good News!, 1976) and launched improved cartridge systems (Atra/Contour, 1977) while quietly funding a long-dated R&D programme aimed at a premium shaving system that Bic could not imitate. Between November 1986 and April 1988 Gillette defeated three takeover attempts — two from Ronald Perelman's Revlon Group and one proxy fight by Coniston Partners — that, if successful, would almost certainly have truncated the R&D pipeline in favour of near-term cash returns. The board's decision to remain independent preserved the pipeline that produced Sensor (launched 1989–1990, roughly $200 million developed cost, $100–175 million launch marketing) and Mach3 (announced April 1998 after roughly $750 million of R&D and manufacturing investment, plus a $300 million ad campaign). Under Mockler's successor Alfred M. Zeien (CEO 1991–1999) the same operating model was extended internationally and complemented by the 1993 acquisition of Parker Pen and the 1996 acquisition of Duracell for $7.3 billion in stock. By early 1999 Gillette's market capitalisation had risen to roughly $63 billion from roughly $6 billion at Mockler's elevation, with global blade-and-razor share well above 60 per cent. The strategic question the episode turned on was whether a consumer-products incumbent could defend a premium-priced category against a credible low-cost substitute by re-investing rather than harvesting — and whether its governance could hold the line through multiple offers to cash out.

2. Sources

Primary:

1. Gillette Co. v. RB Partners, 693 F. Supp. 1266 (D. Mass. 1988) — federal district court opinion arising from the Coniston proxy fight, including factual record on Gillette's defensive actions and board conduct.
2. The Gillette Company, Agreement and Plan of Merger among The Procter & Gamble Company and The Gillette Company (SEC filing, January 2005) and accompanying Form S-4 (SEC EDGAR) — SEC-filed record setting out Gillette's end-state product portfolio (Mach3, Venus, Duracell, Oral-B, Braun) and historical product lineage that anchored the 2005 transaction.
3. UPI Archives, "Gillette chairman dies of heart attack," 25 January 1991 — contemporaneous news report on Mockler's death recording CEO tenure (1975–1991) and Sensor-launch timing.
4. The Washington Post, "Gillette and Coniston Reach Settlement over Proxy Fight," 2 August 1988 — contemporaneous news coverage of the settlement terms ($720 million repurchase of 14.3 per cent of shares, three-year standstill).
5. The Baltimore Sun, "Gillette spends $750 million to make Mach3 — huge covert operation for new production line of three-blade razor," 17 August 1998 — contemporaneous reporting on the Mach3 development budget, plant buildout and secrecy protocol.

Secondary (with justification):

1. Jim Collins, Good to Great: Why Some Companies Make the Leap… and Others Don't (HarperBusiness, 2001), chapter 2 on Level 5 Leadership and the Mockler case — synthesises interview and documentary evidence on the 1986–1988 takeover defence and counterfactual shareholder-return analysis.
2. Rita Ricardo-Campbell, Resisting Hostile Takeovers: The Case of Gillette (Praeger, 1997) — book-length scholarly account by a Gillette director drawing on board records and first-hand accounts of the Perelman and Coniston episodes.
3. "MACH 3: Anatomy of Gillette's Latest Global Launch," Strategy+Business, 1998 — contemporaneous strategy-press analysis of the seven-year Mach3 development programme, 35 patents and global simultaneous-launch logistics.
4. "The Gillette Company," International Directory of Company Histories / Encyclopedia.com entry — aggregates the 1975–1999 operating and acquisition record, including Duracell (1996, $7.3 billion), Parker Pen (1993), and the Sensor developed-cost figure.

Tertiary (flagged):

1. Gillette (Wikipedia) and Colman M. Mockler Jr. (Wikipedia) — used for frame and cross-reference on dates only, not for load-bearing factual claims.

Additional sources identified during Phase 0 §4 generation:

1. FundingUniverse, "History of The Gillette Company," fundinguniverse.com/company-histories/the-gillette-company-history/ — aggregates organisational, divestiture, and blade-technology history including the Wilkinson Sword patent episode and Mockler's divisional capital-reallocation; used for Structure, Direction, and Capability evidence.
2. Thinkers50 / OxGadgets, "Razor Sharp Innovation" / "Gillette R&D — A journey through innovation and implementation," thinkers50.com and oxgadgets.com/2015/03/gillette-rd-a-journey-through-innovation-and-implementation.html — confirms 1979 Sensor development start and $275 million developed-cost figure; used for Direction and Processes evidence.
3. Alfred Zeien — Wikipedia, en.wikipedia.org/wiki/Alfred_Zeien — records Zeien's appointment (February 1991), manufacturing-cost-reduction targets, and international-expansion philosophy; used for Structure and Culture evidence. Flagged tertiary for load-bearing claims; cross-referenced against Chief Executive interview.
4. Chief Executive magazine, "An Iconoclast in a Cutthroat World" (profile of Alfred Zeien), chiefexecutive.net/an-iconoclast-in-a-cutthroat-world/ — contemporaneous interview recording Zeien's explicit manufacturing-process orientation and 4% annual cost-reduction target; used for Processes evidence.
5. Grokipedia, "Colman M. Mockler Jr.," grokipedia.com/page/colman_m_mockler_jr — records Mockler's personal shareholder-contact campaign during the 1988 proxy fight and long-term value vindication (1,655% cumulative return in the decade after); used for Culture evidence. Flagged tertiary; corroborated by Collins, Good to Great and Washington Post primary source.
6. Jim Collins, "Shareflipping Cheats Shareholders of Real Value," jimcollins.com/article_topics/articles/shareflipping.html — contemporaneous article by the Good to Great author reinforcing the long-term return analysis; used as corroboration for Culture evidence.
7. Encyclopedia.com, "Global Gillette" — records Zeien's international distribution strategy and manufacturing-facility footprint (64 facilities, 27 countries); used for Structure evidence.
8. The Christian Science Monitor, "Gillette escapes takeover in a close shave, but the cost is high," 26 November 1986, csmonitor.com/1986/1126/fgill-f.html — contemporaneous news report on the Perelman bid terms ($65/share, $4.2 billion), greenmail characterisation, and settlement structure ($558M repurchase including $9M cost reimbursement to Revlon); used for Direction and Structure evidence.

3. OTA narrative

Observe. Gillette's observation apparatus produced a clean read of its environment across the episode. Management saw, early, that Bic's disposable-razor push was not a fad but a structural substitute attacking the economics of the cartridge franchise, and the company responded with its own disposable (Good News!, 1976) before the U.S. disposable wave crested. Management also read — correctly and against a diversifying peer-group default of the 1970s — that Gillette's durable edge lay in blade metallurgy, manufacturing scale and repeat-purchase distribution, not in conglomerate breadth. During the 1986–1988 takeover period, Mockler and the board observed that the offered premia, while real, reflected short-term arbitrage on an under-communicated R&D pipeline rather than the long-run value of the franchise. The observation task here was hard for the Sustained-Excellence peer group of the late 1970s and 1980s — most consumer-goods incumbents facing a credible low-cost attacker either diversified away or harvested — and the read was non-trivially correct. Observe is not a root cause of the outcome; it was, rather, the phase that carried the strategic value, as a Hard-Correct Observe that consistently produced the signal the reasoning and execution stages then used.

Think. The reasoning step converted the observation into two connected decisions that together defined the episode: (i) re-concentrate the portfolio around the shaving franchise and allied repeat-purchase categories, funding multi-year R&D on a premium system that disposables could not match; and (ii) refuse the 1986–1988 takeover offers on the explicit theory that the in-flight Sensor and later Mach3 programmes would produce shareholder value materially above the offered premia, provided the pipeline was not dismantled. The reasoning was specific, dated and attributable — the portfolio refocus was executed through named divestitures (Buxton 1977, Welcome Wagon 1978, Hyponex and Autopoint 1979), and the takeover-refusal decisions were board-level, minuted, and defended in shareholder communications and in federal court. Think was the decisive phase that carried the strategic value; the reasoning was non-trivial given the takeover premia on offer and the short-termist climate of the period. Think is not a root cause of any failure (there is no failure to explain); it is a Hard-Correct Think that carried the chain from observation to action, and in a success framing it is the phase that converted the read into a commitment the organisation could execute against.

Act. Execution over the 1975–1998 window was technically competent and capability-intensive. Gillette delivered the disposable counter-move (Good News!) in time to blunt Bic in the U.S., shipped Atra/Contour (1977) and the Atra Plus family, and launched Sensor (1989–1990) on roughly $200 million of developed cost with a $100–175 million marketing push across 19 countries. Mach3 (announced April 1998) followed seven years of development, roughly $750 million in combined R&D and continuous-motion manufacturing investment, 35 patents and a $300 million launch campaign — executed under operational secrecy that kept the product from competitors until launch. The defensive-transactions work (the 1986 $558 million repurchase from Revlon at $59.50, the 1988 $720 million repurchase of 14.3 per cent of shares to end the Coniston proxy, the proxy-mailing campaign that produced the 52–48 April 1988 vote) was executed competently under litigation pressure. Act was not a root cause of the outcome in a failure sense, but in the success framing it was a weight-bearing follow-on to the reasoning: execution was Hard-Correct for a Sustained-Excellence peer group, because the Sensor and Mach3 builds required manufacturing capability that competitors could not quickly match. Act functioned as a competent transmission of a correct read and a correct interpretation into a durable market outcome rather than as the decisive step.

4. Modality evidence

Direction. The episode's most load-bearing directional choice was Mockler's decision, upon taking the CEO role in 1975, to reverse his predecessor Vincent Ziegler's diversification strategy and concentrate Gillette's capital in a narrow set of high-volume, repeat-purchase categories where the company's manufacturing, distribution, and blade-technology base could compound (International Directory of Company Histories / Encyclopedia.com). The divestiture programme was discrete and dated: Buxton was sold in 1977, Welcome Wagon in 1978, Hyponex and Autopoint in 1979 — four named assets, four datable decisions, attributable to Mockler and the board (Collins, Good to Great; International Directory of Company Histories / Encyclopedia.com). A second and analytically distinct directional decision was the initiation of the long-dated Sensor R&D programme, begun in 1979 and deliberately insulated from quarter-to-quarter commercial pressure — a choice to fund a ten-year pipeline to a premium-priced system that disposables could not imitate rather than harvesting the cartridge franchise (Thinkers50 / OxGadgets; Ricardo-Campbell, Resisting Hostile Takeovers). Both choices satisfy the Direction Evidence Rule three-prong test: each is specific (identifiable discrete decision), datable (the divestitures within 1977–1979, the Sensor R&D start in 1979), and attributable to named decision-makers with board-level authority in the record. A third directional commitment — the board's explicit rejection of the 1986 Revlon ($65/share) and 1987 follow-on bids, and then the April 1988 Coniston proxy defence — extended the Sensor-era direction into the governance arena, preserving the in-flight pipeline at a direct financial cost of $558 million in the first buyback alone (The Washington Post, 2 August 1988; Collins, Good to Great; Ricardo-Campbell, Resisting Hostile Takeovers). The counterfactual — a successful Perelman acquisition dismantling the Sensor pipeline for near-term cash returns — makes the directional stakes explicit: the choice to remain independent was not passive but active, board-level, documented, and defended in federal court (Gillette Co. v. RB Partners, 693 F. Supp. 1266).

Structure. Mockler's portfolio concentration restructured Gillette's resource allocation architecture, shifting capital from diversified consumer lines back to the Safety Razor Division and its allied R&D and manufacturing infrastructure (International Directory of Company Histories / Encyclopedia.com; FundingUniverse company history). The four-division structure that Gillette had maintained since 1971 (Safety Razor, Toiletries, Personal Care, Paper Mate) remained intact as the formal unit architecture, but its relative weight changed substantially as undifferentiated businesses were divested and the blade franchise received renewed capital priority. Structurally, the Mach3 programme operated under a deliberate compartmentalisation protocol internally codenamed "225": Gillette built physical barriers (plywood walls) inside its South Boston factory, involved the FBI to manage potential leaks, and parcelled work to subcontractors so that no single vendor obtained the complete production picture — an architecture that served both intellectual-property protection and competitive-secrecy purposes (Baltimore Sun, 17 August 1998; Strategy+Business, 1998). Under Zeien (CEO from February 1991), Gillette extended the same structural logic internationally: 64 manufacturing facilities in 27 countries, with the blade business used as a distribution-channel anchor that subsequently reduced per-unit costs for other product lines introduced into the same markets (Encyclopedia.com, "Global Gillette"; Alfred Zeien — Wikipedia). Structural authority over global launch sequencing and manufacturing investment rested at the corporate CEO level, which allowed Zeien to make the global-simultaneous-launch decision for both Sensor (1990, 16 countries) and Mach3 (North America June 1998, Europe September 1998) as a single, coordinated commitment rather than a market-by-market roll-out (Strategy+Business, 1998).

Scoring note (zero-modality rationale): the structural arrangements described in this subsection are classified primarily under Direction in the scoring record on the rationale that the strategic value derived from a specific, datable strategic choice that the architecture happened to host rather than from a novel divisional architecture or governance design (Gillette retained a conventional reporting hierarchy across the episode). The dedicated structural elements are counted as the operational substrate of the Direction modality rather than as an independent Structure contribution. Categorisation under METHODOLOGY-ota-scoring-v4.md §5: classification boundary with an adjacent modality. This follows the S-006 (Cisco) precedent for Structure-as-Processes-substrate.

Processes. Gillette's operational discipline in blade R&D and manufacturing constitutes the clearest Processes evidence in the episode. The Sensor development cycle (1979 initiation, 1990 launch) institutionalised a multi-year innovation process in which the technical trajectory — spring-mounted twin blades that independently adjusted to facial contours — was held stable through market pressure and takeover threat, indicating a planning and funding cycle that was not reset by short-term performance volatility (Thinkers50 / OxGadgets; Ricardo-Campbell, Resisting Hostile Takeovers). The competitive-intelligence and product-launch process for Mach3 was operationally elaborate: seven years of development (1991–1998), 35 patents, a covert manufacturing build-out, a global-launch sequencing plan, and a $300 million two-year advertising campaign rolled out with military-precision timing — all elements of co-ordinated operational machinery rather than individual judgement calls (Baltimore Sun, 17 August 1998; Strategy+Business, 1998). Zeien's explicit manufacturing-process orientation reinforces this reading: he stated publicly that Gillette spent more on designing new production equipment than on new products, and targeted annual manufacturing-cost reductions of 4 per cent — a process discipline applied across cycles and product generations, not attached to a specific individual (Chief Executive interview / "An Iconoclast in a Cutthroat World"). The Processes / Capability boundary test asks whether this edge would survive staff replacement with equally talented strangers: the product-development pipeline, the covert production-line build protocol, the global-launch sequencing system, and the manufacturing-cost-reduction target were documented, institutionally embedded, and procedural in nature — they would largely survive staff turnover. This positions them primarily in Processes rather than Capability, though both are present.

Capability. Gillette's institutional capability in blade metallurgy and manufacturing engineering was the technical foundation that made the directional and process choices executable. The company had developed proprietary thin-wire-edge metallurgy, chromium-platinum blade coating, and the spring-blade assembly technology that produced the Sensor's defining feature (independent blade suspension), and by 1998 the Mach3 production lines ran at 600 cartridges per minute against the 250-per-minute limit of prior Sensor lines — a four-year, capital-intensive engineering programme producing a manufacturing capability that no competitor could quickly replicate (Baltimore Sun, 17 August 1998; Strategy+Business, 1998). The Mach3 blade employed an ion-deposition surface treatment and laser-welded precision assembly that together constituted 35 patents — technical assets whose development required deep institutional knowledge of materials science and high-speed precision manufacturing, not just process documentation (Strategy+Business, 1998; Baltimore Sun, 17 August 1998). The historical parallel with Wilkinson Sword's 1962 coated-stainless-steel challenge is relevant context: Gillette not only matched the coating technology but managed to patent the production method before Wilkinson, converting a competitive threat into a royalty income stream — a demonstration of institutional capability in translating laboratory insight into defensible IP (FundingUniverse company history). However, the Processes / Capability boundary test flags that much of Gillette's manufacturing edge was embedded in equipment, systems, and documented protocols rather than solely in named individuals: the capability was real but partially systematised, making Structure and Processes co-claimants for some of what appears here as capability. Confidence in assigning capability-primary weight to the manufacturing and metallurgical assets is moderate; raters should note the overlap with Processes.

Scoring note (zero-modality rationale): the Capability contribution described in this subsection is classified at the boundary with Direction in the scoring record — the §4 evidence locates the operative driver of the episode's value in Direction rather than in a standalone Capability contribution. Capability is acknowledged in narrative as evidenced but does not carry independent weight in the scoring; weight is borne by Direction, Processes, Culture. Categorisation under METHODOLOGY-ota-scoring-v4.md §5: classification boundary with an adjacent modality.

Culture. The cultural evidence in this episode clusters around the behavioural defaults that repeatedly held the organisation to its long-term orientation under acute short-term pressure. Mockler personally called thousands of individual shareholders during the April 1988 Coniston proxy campaign to make the long-term value case — a norm-setting act by the CEO that communicated to employees and the board alike that the company's identity was defined by the R&D pipeline, not by arbitrage premia (Collins, Good to Great; Grokipedia, "Colman M. Mockler Jr."). Collins's reconstruction of the episode, drawing on participant accounts, characterises Mockler's leadership style as self-effacing persistence rather than charismatic command — a cultural framing in which the organisation's norms outlasted any individual's personal authority. The fact that Zeien, upon succeeding Mockler in February 1991, extended the same long-dated R&D and manufacturing-investment philosophy internationally without restructuring the model is consistent evidence of an institutional norm rather than a single leader's personal preference (UPI Archives, 25 January 1991; Alfred Zeien — Wikipedia; Encyclopedia.com). The Gillette-Coniston contest is especially diagnostic for Culture: the 52–48 April 1988 proxy vote was narrow enough that the outcome was not structurally determined — the board's governance mechanisms were functional but the margin was slim, meaning the cultural willingness of Mockler's team to sustain the proxy defence under adverse odds was independently load-bearing (Washington Post, 2 August 1988; Gillette Co. v. RB Partners, 693 F. Supp. 1266). The Direction / Culture boundary test asks whether the organisation knew where to go but couldn't bring itself to go there (Culture) or whether the directional choice itself was the differentiating act (Direction): here the directional choice and the cultural will to hold it under fire are analytically separable — the choice was made in 1975–1979 (Direction), but the sustained refusal to abandon it during three takeover bids in 1986–1988 is more accurately classified as a cultural behavioural default than a repeated independent strategic decision.

---